Riley Kandel
Advertisement
Articles by Riley Kandel
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
HMA/Venetoclax Is Superior to Intensive Chemo in Fit Patients With AML
2
The Targeted Pulse: FDA Approvals, Trial Updates, and ASH 2025 Previews
3
BRUIN Final Analysis: Pirtobrutinib Durable in Post-Covalent BTK CLL/SLL
4
Chemo-Free Ponatinib/Blinatumomab Improves Survival in Ph+ ALL
5
